MFP
CRL icon

Meramec Financial Planners’s Charles River Laboratories CRL Stock Holding History

Meramec Financial Planners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34
Closed -$6.31K – 566
2026
Q1 		$6.31K Hold
34
– – ﹤0.01% 363
2025
Q4 		$6.43K Buy
+34
New +$6.17K ﹤0.01% 373

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Meramec Financial Planners's CRL Position: Q2 2026 in Review

Meramec Financial Planners sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 34 shares — an estimated $6.31K sold.

Meramec Financial Planners first reported a position in CRL in Q4 2025 and held it in 2 quarters. The position peaked at $6.43K in Q4 2025. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Meramec Financial Planners reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Meramec Financial Planners sold 34 Charles River Laboratories shares in Q2 2026, an estimated $6.31K.
  • Meramec Financial Planners first reported a position in Charles River Laboratories in Q4 2025 and held it in 2 quarters.
  • Meramec Financial Planners's Charles River Laboratories position peaked at $6.43K in Q4 2025.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Meramec Financial Planners's 13F filing for Q2 2026, filed 29 Jul 2026.